RUNX3 and head and neck cancer: Finally, the gene expression levels of RUNX3, TGF-β (a RUNX3-regulating growth factor), and PTHrP (a RUNX3-regulated osteolytic factor) were higher in the tissues of patients with head and neck cancer, including oral cancers, than in normal tissues.